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Abstract 
The objective of this study was to compare the effect of multisensory stimulation environment (MSSE) and one-to-
one activity sessions in the symptomatology of elderly individuals with severe dementia. Thirty-two participants were 
randomly assigned to the following 3 groups: MSSE, activity, and control group. The MSSE and activity groups 
participated in two 30-minute weekly sessions over 16 weeks. Pre-, mid-, and posttrial; 8-week follow-up behavior; 
mood; cognitive status; and dementia severity were registered. Patients in the MSSE group demonstrated a significant 
improvement in the Neuropsychiatric Inventory and Bedford Alzheimer Nursing Severity Scale scores compared with 
the activity group. Both MSSE and activity groups showed an improvement during the intervention in the Cohen-
Mansfield Agitation Inventory aggressive behavior factor and total score, with no significant differences between 
groups. The MSSE may have better effects on neuropsychiatric symptoms and dementia severity in comparison with 
one-to-one activity sessions in patients with severe dementia. 
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Introduction 
The clinical spectrum of dementia is a continuum where the earlier signs may be barely discernible, 
and the later signs overt and complex. Those with advanced disease present a wide range of symptoms 
which include marked cognitive, language, and functional impairment and significant neuropsychiatric 
symptoms.
1,2
  
Although nowadays there are available pharmacologic treatments to deal with dementia symptoms, it 
is recognized that they have modest efficacy and notable risks, especially in people with severe dementia. 
Hence, nonpharmacologic interventions have been recommended as first-line treatments.
3,4
 In the last 
years, the evidence supporting the efficacy of nonpharmacological approaches has increased,
5,6
 however, 
most of the studies have focused on mild–moderate stages of illness. Given that patients with severe 
cognitive impairment may not necessarily respond to treatments in the same manner than those with mild 
to moderate cognitive impairment, it is necessary to explore the stage-specific efficacy of 
nonpharmacological therapies for patients with severe dementia.
7
  
One of the interventions that could be suitable for reaching persons with severe or very severe 
dementia is multisensory stimulation environment (MSSE). Multisensory stimulation environment was 
developed in the Netherlands in the 1970s and was first introduced for people with learning difficulties. 
Since the beginning of the 1990s, the MSSE has been used as a nonpharmacological therapy in people 
with dementia.
8
 The MSSE typically occurs in a pleasant and relaxing room known as Snoezelen room. 
Visual, auditory, tactile, and olfactory stimulation is offered to patients in this room using a variety of 
lights, fiber-optic cables, water columns, aroma therapy, different music/sounds, tactile objects, and 
screen projectors.
9,10
 The main features of Snoezelen are one-to-one attention and the adoption of a 
nondirective approach, encouraging patients to engage with sensory stimuli of their choice,
10
 being 
compatible with the person-centered care philosophy.
11,12
  
Snoezelen aims to stimulate the primary senses without the need for intellectual activity from the 
patient. Stimuli used are nonsequential and unpatterned, experienced moment by moment without relying 
on short-term memory to link them to previous events
10
 Thus, it could be an especially appropriate 
intervention for dealing with people in advance stages of dementia,
13
 where verbal communication is 
markedly impaired.  
Elderly people with severe dementia living in nursing homes are often sensory deprivated or, on the 
contrary, they are exposed to an excessive sensory stimulation. The Model of Imbalance in Sensoristasis 
(MIS)
14,15
 suggests that agitated behaviors may be initiated or exacerbated due to the imbalance between 
sensory-stimulating and sensory-calming activity. The hypothesis of this model is that achieving a 
balance between the sensory-stimulating and the sensory-calming activities will decrease agitation, 
ameliorate other behavioral symptoms, and prevent functional decline. Therefore, MSSE constitutes an 
adequate intervention because it can have both stimulating and calming effects, and it can be used to 
ameliorate both disengaged and high-arousal needs.  
Nowadays, the evidence suggesting that MSSE is more effective than individualized interventions for 
reducing neuropsychiatric symptoms in patients with severe dementia is very limited.
16
 Very recently it 
has been found
17,18
 that MSSE in a Snoezelen room was as effective as individualized activity sessions 
improving the neuropsychiatric symptoms of people with mild to severe dementia (Global Deterioration 
Scale GDS 4-7).
19
 This broad spectrum of participants’ cognitive status could be blurring the data and 
explaining the few significant differences found between both interventions. This study is presented as a 
continuation of the previous one to test the hypothesis that people in advanced stages of dementia (GDS 
6-7) may benefit more from MSSE than from more cognitively demanding one-to-one activities. 
Therefore, the main objective of the current study was to compare the effect of MSSE in a Snoezelen 
room and one-to-one activity sessions on to the behavior, mood, cognitive status, and dementia severity 
of institutionalized elderly individuals with dementia.  
Methods 
Design 
A pilot randomized controlled trial was conducted among older participants aged 65 years or older, 
stratified according to their cognitive status being afterward randomly assigned to one of the 3 groups 
(MSSE, activity, and control).  
Participants 
The sample was selected among the residents of a specialized dementia elderly center in A Coruña 
(Spain). The inclusion criteria were a diagnosis of dementia and the presence of severe or very severe 
cognitive decline (GDS, 6-7)
19
. Dementia diagnoses was noted on the medical history and provided by a 
neurologist before placement in the gerontological complex, being corroborated by the elderly center’s 
medical doctor. GDS was applied by a clinical psychologist with experience in assessing people to 
determine level of severity: severe (GDS 6) or very severe (GDS 7) cognitive decline. The exclusion 
criteria were the presence of a sensory disorder that would adversely affect interactions with the 
multisensory stimulation objects (eg, severe vision and hearing impairment) and be bedridden.  
After the clinical psychologist checked the eligibility of participants according to the inclusion and 
exclusion criteria, the sample consisted of 32 participants. A computer-based random number generator 
was used to randomly divide the sample into 3 groups of 11, 11, and 10 individuals according to GDS. 
The initial sample size decreased to 27 during the follow-up period due to participant deaths (n = 4) and 
dropouts (n = 1). The patients’ progress through the trial is shown in a Consolidated Standards of 
Reporting Trial (CONSORT) diagram (Figure 1).  
  
 
 
 
Figure 1. Consolidated Standards of Reporting Trial (CONSORT) diagram. MSSE indicates multisensory stimulation environment. 
The study protocol was approved by the Ethics Committee at the University of A Coruña followed the 
principles of the Declaration of Helsinki. Before beginning data collection, all participants’ proxies were 
informed about the study. Proxies were used as legally authorized representatives to provide informed 
consent for the elderly individuals having dementia to participate in the research.  
Procedure 
People from the MSSE group participated in multisensory sessions in a Snoezelen room. This room, 
that stimulate all the senses except taste, included several elements such as alternating colors fiber-optic 
cables, 2 water bubble columns within 2 mirrors, a water bed, a rotating mirror ball with a color light 
projector, a video, an interactive projecting system, musical selections, aroma therapy equipment with 
fragrant oils, and a tactile board with various textures, among others.  
The activity group participated in a series of one-to-one activity sessions, in which intellectual and/or 
physical demands were placed on the individual, and the approach used is directive, being the therapist 
the person responsible to choose the activities to be performed. Participants were asked to take part in 
simple activities such as looking at photographs or playing games. This group was included in the study 
to differentiate the specific benefits of the multisensory stimulation from those derived from attending 
one-to-one therapy sessions.
13
  
The control group did not participate in any of the aforementioned activities; rather, this group 
continued with the daily routines of the center, including cognitive stimulation group sessions (GDS 6), 
training on activities of daily living (GDS 6), education and training of nursing assistants in dementia 
knowledge, acknowledgment of resident’s experiences, and communication techniques and behavior 
management (GDS 6-7).  
The design of the sessions followed by the MSSE and the activity groups was based on the protocol 
suggested by Baker et al.
20
 Participants from both groups were required to take part in 2 weekly sessions, 
for a period of 16 weeks, until they complete 32 sessions. These sessions lasted 30 minutes, unless the 
participant expressed a desire to leave.  
The difference between MSSE and activity sessions was given by the characteristics that define the 
MSSE. In the MSSE group, multisensory unpatterned stimuli were used, the therapist followed a 
nondirective approach, and the therapy required few intellectual or physical demands. In contrast, during 
the activity sessions, no intentional special multisensory experiences were introduced, the therapist 
followed a directive approach, and intellectual and/or physical demands were placed on the patient.  
Data on participants’ sensorial preferences and interests were previously collected to design the 
content of the sessions and to minimize the behavioral problems that some participants could present 
within the MSSE and the activity contexts. In the MSSE group, sensorial preferences in the Snoezelen 
room were assessed based on the procedure suggested by Pace et al.
21
 Furthermore, relatives of 
participants of both groups were interviewed to identify participants’ hobbies and interests.  
Behavior, mood, cognition, and dementia severity were assessed at baseline (pretrial, week 0), in the 
middle (midtrial, week 8), at the end of the intervention (posttrial, week 16), and 8 weeks after the 
intervention (follow-up). Due to ethical reasons, the control group did not remain without intervention for 
more than 16 weeks; therefore, this group did not participate in the 8-week follow-up.  
Assessment Instruments 
The validated Spanish version
22
 of the Cohen-Mansfield Agitation Inventory (CMAI)
23
 was used to 
assess the frequency of agitated behaviors in the participants. The CMAI consists of 30 items that are 
each rated on a 7-point scale of frequency, 1 meaning never and 7 several times per hour. The total score 
is calculated by summing the scores of each of the individual items. Through a factor analysis, Cohen-
Mansfield et al
23
 found the following 3 factors of agitation in the nursing home: “aggressive behavior” 
(hitting, kicking, pushing, scratching, tearing things, cursing or verbal aggression, and grabbing); 
“physically nonaggressive behavior” (pacing, inappropriate robing or disrobing, trying to get to a 
different place, handling things inappropriately, general restlessness, and repetitious mannerisms); and 
“verbally agitated behavior” (complaining, constant requests for attention, negativism, repetitious 
sentences or questions, and screaming). In this study, for each factor the total score was obtained by 
summing the scores of the corresponding items. The CMAI interrater reliability
23
 ranges from .88 to .92 
and the internal consistency reliabilities (Cronbach’s α)24 range from .86 to .91.  
Behavior was assessed using the Spanish version
25
 of the Neuropsychiatric Inventory (NPI).
26
 This 
scale was developed to assess a wide range of behaviors in patients with Alzheimer’s disease and other 
dementias. The NPI questionnaire evaluates 12 neuropsychiatric disturbances including delusions, 
hallucinations, agitation, dysphoria/depression, anxiety, euphoria, apathy, disinhibition, irritability, 
aberrant motor behavior, sleep and night-time behavior disturbances, and changes in appetite and eating 
behaviors. Neuropsychiatric Inventory is completed according to the answers of the caregivers. A group 
of screening questions are asked first, which are followed by a series of subsequent questions if the 
response to the initial screening indicates the presence of neuropsychiatric alterations. The caregiver rates 
the frequency of the symptoms using scores from 1 to 4 (1 = occasionally, less than once per week; 4 = 
very frequently, once or more per day or continuously) and also rates the severity using scores from 1 to 3 
(1 = mild, 2 = moderate, and 3 = severe). The total score ranges from 0 to 144, with higher values 
indicating more behavioral and psychological alterations. The Spanish version of the NPI
25
 has shown 
good internal consistence (α = .85) and interrater reliability (.63 to 1.00).  
The Spanish version
27
 of the Cornell Scale for Depression in Dementia (CSDD)
28
 was used to assess 
mood. This scale was specifically developed to assess signs and symptoms of major depression in patients 
with dementia. Information is elicited through 2 semistructured interviews: an interview with an 
informant and an interview with the patient. The CSDD consists of 19 items that are rated for severity on 
a scale of 0 to 2 (0 = absent, 1 = mild or intermittent, 2 = severe). Total score is obtained by summing the 
scores for all items, being the minimum score 0 and the maximum score 38. Scores above 10 indicate 
probable major depression. Scores above 18 indicate definite major depression. In the Spanish population, 
CSDD has shown good test–retest reliability (.61 to .84) and good internal consistency (α = .81).27  
To assess cognitive function, the Spanish version
29
 of the Severe Mini-Mental State Examination 
(SMMSE)
30
 was used. The SMMSE was designed for assessment of severe dementia preventing the floor 
effect found when using the MMSE.
31
 This simple instrument does not require specialized training or 
foreign material, and it is not tiring for the patient with dementia (takes less than 5 minutes to administer). 
It consists of 10 items related with autobiographical knowledge (complete name and birth date), 
constructional praxis tests, phonological loop (spelling), and semantic verbal fluency step (animal 
category generation). The SMMSE also tests receptive and expressive language skills, along with 
elementary executive functions and visual–spatial abilities, which are likely to be preserved in patients 
with severe impairment. The total score ranges from 0 to 30 points, with lower values indicating lower 
cognitive function. The SMMSE has shown both construct and criterion validity for assessing patients 
with severely impaired Alzheimer’s disease.30 In the Spanish population, SMMSE has shown high 
internal consistency (α = .88), test–retest reliability (.64 to 1.00), interrater reliability (.69 to 1.00), and 
construct validity in correlation with the Spanish version of the Mini-Mental State Examination (Pearson 
r coefficient = .59).
29
  
  
The overall severity of dementia was measured by the Bedford Alzheimer Nursing Severity Scale 
(BANS-S).
32
 The BANS-S is an observational scale that can be used even with persons who are unable to 
follow simple commands, uncooperative, or unable to communicate. This is a 7-item scale that combines 
ratings of interaction ability (speech, eye contact), functional deficits (dressing, eating, and ambulation), 
and occurrence of pathological symptoms (sleep–wake cycle disturbance, muscle rigidity).33 Each item is 
scored on a 4-point scale where a scoring system is specified for each item. The total score ranges from 7 
(no impairment) to 28 (most severe impairment). The BANS-S is more sensitive to detecting disease 
progression beyond the severe stage than scales that measure only cognitive or functional deficits.
32
 
BANS-S has shown good internal consistence (α = .80), convergent validity with other cognitive and 
functional scales (r = .62-.79), and discriminant validity in comparison with the NPI (r = .36).
32,34
  
Statistical Analysis 
Sample characteristics were summarized as mean and standard deviation (SD) for the continuous 
variables and as frequency and percentage for the categorical variables. The Shapiro-Wilk test was used 
to evaluate the normality of the sample. This test is more appropriate for small sample sizes (< 50 
samples).
35
 Differences between groups at baseline were compared using chi-square test for proportions 
and the nonparametric Mann Whitney U test for nonnormally distributed continuous variables. Statistical 
significance was set at a P value of less than .05.  
Finally, repeated measures two-way analysis of variance (two-way mixed ANOVAs) (two-way mixed 
ANOVAs) was used to assess performance differences in behavior, mood, and cognitive status and 
dementia severity over the pre-, mid-, and posttrial assessment points. In the first analysis, the within-
subject variable was the measures over time (pre-, mid-, and posttrial assessment) and the between-
subject variable included the group (MSSE and activity). In the second analysis, the within-subject 
variable was the measures overtime (pre-, mid-, and posttrial assessment) and the between-subject 
variable included the group (MSSE and control).  
In addition, repeated measures two-way mixed ANOVAs were used to assess performance differences 
in behavior, mood, and cognition, and dementia severity between the posttrial and the 8-week follow-up. 
In this case, the within-subject variable was the measures over time (posttrial assessment and follow-up) 
and the between-subject variable included the group (MSSE and activity).  
Differences between groups were tested by a group–time interaction. Eta-squared values (η2) were 
reported as indicators of effect size. We interpreted the importance of the effect size using the 
benchmarks for “small” (η2 of .02), “medium” (η2 of .13) and “large” (η2 of .26) offered by Cohen 
(1988).
36
 Statistical significance was set at a P value of less than .05. Statistical analysis was performed 
using the SPSS version 20.  
Results 
Table 1 shows the sociodemographic characteristics of the sample, differentiated by groups, at 
baseline. The mean age of the sample (n = 32) was 85.5 years (SD ±8.46). Of participants, 78.1% were 
women. Regarding marital status, 62.5% of the patients were widowed. Concerning education level, 
28.1% had secondary education.  
At baseline, the groups were homogeneous. There were no significant differences, neither between the 
MSSE group and the activity group nor between the MSSE group and the control group in age, gender, 
marital status, or educational level. Significant differences only between the activity group and the control 
in gender, marital status, and educational level were found. 
  
 
 
Effect on Behavior 
With regard to agitation, as assessed by the CMAI, when comparing the MSSE group and the activity 
group, an improvement in both groups in the aggressive behavior factor (F 2,38 = 8.200, P = .001, η
2
 = 
.300) and in the total score (F 2,36 = 6.990, P = .003, η
2
 = .277) between pre-, mid-, and postintervention 
(Figure 2) was observed. However, no significant differences were found between groups. For both 
groups, the scores worsened in the follow-up period compared to the posttrial assessment in the 
aggressive behavior factor (F 1,16 = 11.983, P = .003, η
2
 = .420) and in the CMAI total score (F 1,16 = 
14.031, P = .002, η2 = .467), with no significant differences between the groups. With regard the verbally 
agitated factor, the scores improved from the pretrial to the posttrial in the 2 groups, although the results 
were not statistically significant. Between the posttrial assessment and the follow-up period, the scores 
worsened in both groups (F 1,16 = 15.623, P = .042, η
2
 = .456).  
 
 
 
Figure 2. Cohen-Mansfield Agitation Inventory (CMAI) during the trial and 
follow-up—verbally agitated behavior (A), physical nonaggressive (B), aggressive 
behavior (C), and total score (D). Higher scores = worse agitated behavior. 
+Significant group-time interaction effect from pre- to posttrial (MSSE-control; P < 
.005). MSSE indicates multisensory stimulation environment.  
  
When comparing the MSSE group and the control group, group-time interactions in verbally agitated 
behavior and in the CMAI total score were observed. Specifically, an improvement in verbally agitated 
behavior (F 2,36 = 3.460, P = .042, η
2
 = .155) and in the CMAI total score (F 2,36= 11.755, P < .001, η
2
 = 
.301) from the pretrial to the posttrial in the MSSE in comparison with the control group was found. For 
the aggressive behavior factor, significant time effects (F 2,36 = 3.632, P = .037, η
2
 = .160) were also 
observed among pre-, mid-, and postintervention results, with a decrease in the scores for both groups.  
With regard to physically nonaggressive behavior, no significant time effects or intergroup differences 
were found. 
A significant group–time interaction effect was also found when comparing the NPI scores in the 
MSSE group and in the activity group (Figure 3). Patients in the MSSE group showed a significant higher 
improvement than the activity group from pretrial to posttrial (F 2,36 = 6.2121, P = .005, η
2
 = .238), with 
no significant differences between MSSE and control groups.  
 
 
 
Figure 3. Neuropsychiatric Inventory (NPI) total scores 
during the trial and follow-up (higher scores = worse 
behavior). *Significant group—time interaction effect 
from pre- to posttrial (MSSE-activity; P < .005). MSSE 
indicates multisensory stimulation environment.  
Effect on Mood 
The CSDD scores remained stable during the intervention period in the 3 groups (Figure 4). In the 
follow-up period, the CSDD scores in the MSSE and in the activity group worsened compared to posttrial 
assessment. However, the results were not significant.  
 
 
 
Figure 4. The Cornell Scale for Depression in Dementia (CSDD) 
total scores during the trial and follow-up (higher scores = worse 
mood). MSSE indicates multisensory stimulation environment.  
  
Effect on Cognitive Status 
With regard to SMMSE, when comparing the MSSE group and the activity group (Figure 5), both 
groups displayed an improvement in their scores during intervention. Between the posttrial and the 
follow-up period, a significant time effect was observed, with an important decrease in the scores of both 
groups (F 1,15 = 7.276, P = .017, η
2
 = .324), with no significant differences between the 2 groups.  
 
 
 
Figure 5. Severe Mini-Mental State Examination (SMMSE) total 
scores during the trial and follow-up (lower scores = worse 
cognitive state). MSSE indicates multisensory stimulation 
environment.  
When comparing the MSSE group and the control group, no significant time effects or intergroup 
differences were found. 
Effect on Dementia Severity 
For the BANS-S (Figure 6), there was an improvement in the scores between pre-, mid-, and 
postintervention assessments in the MSSE group but not in the other groups. Significant interaction 
effects between group and time when comparing the MSSE group with the activity group (F 2,36 = 4.126, 
P = .024, η2 = .171) and with the control group (F 2,36 = 11.578, P < .001, η
2
 = .334) were observed.  
  
 
 
 
Figure 6. Bedford Alzheimer Nursing Severity Scale (BANS-S) 
total scores during the trial and follow-up (higher scores = more 
severe impairment). *Significant group–time interaction effect from 
pre- to posttrial (MSSE-activity; P < .005); +Significant group–time 
interaction effect from pre- to posttrial (MSSE-control; P < .005). 
MSSE indicates multisensory stimulation environment.  
Discussion 
Effect on Behavior 
In the current study the NPI scores improved significantly after 16 weeks of intervention in the MSSE 
group in comparison with the individualized activities group. For interpreting the effect sizes, we have not 
found previous studies to compare with, so the benchmarks of Cohen (1988)
36
 have been used. According 
to them, the effect size was large. Previous studies
10,13,17
 found that both MSSE sessions as one-to-one 
preference-based activity interventions could have positive long-term effects (that is, the maintenance of 
the positive effects of the MSSE outside of the session time and place) on neuropsychiatric symptoms of 
older adults with moderate to severe cognitive impairment living in nursing homes. In patients with 
moderate cognitive impairment benefits of intervention can be attributed to the individualized attention 
rather a specific treatment modality. However, people in the later stages of the disease, with very low 
level of functioning, may benefit more from sensory interventions, like MSSE, than from more cognitive 
demanding activities.  
As cognitive function deteriorates, the world is experienced at a sensory level and the environment 
needs to be managed carefully to make it understandable and comfortable.
37
 Consequently, individuals 
with severe dementia specially need an appropriate environmental structure and stimulation, which can be 
achieved by sensory interventions.
38
 The Guideline on Supporting People with Dementia and Their 
Carers in Health and Social Care developed by the National Institute for Health and Clinical Excellence 
and the Social Care Institute for Excellence (NICE-SCIE)
39
 highlighted that in the late stages of dementia, 
sensory stimulation is the primary form of psychological intervention to reduce neuropsychiatric 
symptoms. In this sense, Baker et al
13
 studied the effects of an Snoezelen intervention in comparison with 
a control group that followed one-to-one activity sessions and found that, in the severe cognitive range, 
the Snoezelen group was significantly less apathetic after 8 weeks of intervention. Indeed, there is 
evidence that others forms of sensory interventions, like music interventions
40
 or aromatherapy with 
essential oils,
41
 also show good results in reducing neuropsychiatric symptoms of people with severe 
dementia.  
Regarding agitated behavior, an improvement in the verbally agitated behavior factor and in the 
CMAI total score in the MSSE group in comparison with the control group was found. An improvement 
with the intervention in both MSSE and activity groups in the aggressive behavior factor and in the CMAI 
total score was also observed. As stated earlier, according to the benchmarks of Cohen (1988),
36
 the effect 
sizes were large. These results indicate that although MSSE may be an appropriate intervention to reduce 
agitation in advanced dementia, its efficacy is equivalent to the individualized one-to-one activities.  
  
In this study, the improvements observed in the behavior during the intervention disappeared in the 
follow-up in both groups. This is consistent with the previous studies comparing the effect of MSSE and 
activity groups in moderated to severe dementia,
13,17
. In this regard, O’Connor et al42,43 in a systematic 
review about the psychosocial treatments in people with dementia concluded that the benefits of the 
intervention on behavioral symptoms of dementia defrayed quickly with time. Therefore, to hope that 
repeated exposures to a treatment would consolidate benefits in the follow-up could be a too ambitious 
approach.  
Effect on Mood 
Although intervention in Snoezelen rooms has demonstrated to improve the mood of people with 
dementia at short term, long-term effects were not so evident.
16
 The current results found neither benefit 
after 16 weeks of intervention in the CSDD scores of people with severe dementia nor significant 
differences between the MSSE group and the other 2 groups. In another previous study with people with 
moderate to severe dementia,
17
 neither an improvement in the CSDD scores during the intervention, nor 
differences between the groups was found. In the study of Baker et al,
13
 MSSE was not found to be more 
effective that one-to-one activities in changing the mood neither in people with moderate dementia nor in 
those with severe dementia.  
However, with the MSSE integrated in the daily care, better results have been observed on the mood 
of people with dementia. In the MSSE integrated in the daily care, the intervention was carried out during 
morning care, when the staff were engaged with residents in activities relating to bathing, grooming, 
dressing, and toileting.
44
 Van Weert et al,
45
 observed that patients with moderate to severe dementia 
receiving this type of intervention demonstrated a significant improvement in their level of depression 
after 15 months of treatment in comparison to the control group who received the usual care. Therefore, 
for future work it would be interesting to investigate the effect of MSSE integrated in daily care 
specifically in people with severe dementia.  
Effect on Cognitive Status 
Previous studies in people with moderate to severe dementia
13,17
 have not found significant effects of 
the MSSE on the cognitive level or significant differences between MSSE and one-to-one activity 
sessions. The present study showed an improvement in the SMMSE scores during the intervention in 
MSSE and activity groups, although it was not significant. However, for both groups, a significant 
worsening in the scores was found between the posttrial and the follow-up period. Consequently, in 
people with severe dementia, one-to-one attention could have a positive efficacy on the maintenance of 
cognitive function.  
Effect on Dementia Severity 
With regard to BANS-S scores, patients in MSSE group showed a significant improvement during the 
intervention, which was not observed in the other 2 groups. According to the benchmarks of Cohen,
36
 the 
effect sizes were large. There are limited studies that analyze the effect of MSSE on functional status of 
people with dementia. In patients with moderate to severe dementia, it has also been observed that a more 
structured approach of multisensory stimulation
46,47
 has short-term positive effects on the functional 
status, however there are very room on the balance in individuals with dementia after 6 weeks of 
intervention few data on the long-term effectiveness. Klages et al
48
 found no significant effects of a 
Snoezelen nor significant differences compared with the control group, who received one-to-one visits by 
volunteers. In another previous study,
17
 long-term benefits of MSSE on the functional status (Barthel 
index score) in people with moderate to severe dementia were not found. A possible reason for that could 
be that the Barthel index no assesses well the impact of the intervention in the functional status, especially 
in people with severe dementia. In the current study, this limitation was solved by focusing in people with 
severe dementia, using the BANS-S, a tool more sensitive to detect disease progression for this group of 
people.  
These results highlight that MSSE could be an appropriate intervention in people with severe 
dementia, and support the MIS, according to which balancing time periods of high arousal and low 
arousal in people with dementia can delay their functional decline.  
  
Limitations and Recommendations for Future Research 
The sample may seem small but it should be considered the difficulty of getting more participants, 
especially taking into account their homogeneity and the possibility to be randomized. Therefore, future 
empirical studies with larger samples are needed.  
The use of MSSE in a Snoezelen room requires the investment of economic resources greater than 
those required in other sensory therapies for people with dementia. The future research should conduct 
randomized control trials to examine whether the Snoezelen benefits are better than those provided by 
other sensory interventions, like individualized music or aromatherapy interventions.  
Further, it would be interesting to compare the traditional MSSE in a Snoezelen room, which follows 
a nondirectional approach, with a more structured MMSE, like the functional analytic multisensory 
environmental therapy,
49
 for people with severe dementia.  
The MSSE integrated in daily care could be also an adequate intervention for people with severe 
dementia, because of the high frequency of neuropsychiatric symptoms during morning care in patients in 
the final phase of dementia.
50
 Therefore, it would be interesting that future studies analyze the effect of 
MSSE integrated in daily care in people with severe dementia and compare it with the MSSE carried out 
in a Snoezelen room.
51,52
  
Conclusions 
These results support the idea that MSSE could be more effective than one-to-one activity sessions for 
reducing symptoms in patients with severe dementia. In the current study, a positive effect on 
neuropsychiatric symptoms and dementia severity in the MMSE treatment was observed in comparison 
with the activity group. With regard to agitation, the improvement in the MSSE and the activity group 
was similar, with no significant differences between the 2 types of intervention. However, in general, the 
improvements found during the intervention were lost in the follow-up period, indicating that it is 
necessary to continue with the intervention over time to maintain the positive effects.  
Future research should conduct specific studies with people in advanced stages of dementia to 
compare the effect of MSSE in a Snoezelen room with other types of intervention, like individualized 
music or functional analytic multisensory environmental therapy.  
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